Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Oryza sativa subsp. japonica Barley B recombinant-like protein C (Os10g0115500, LOC_Os10g02620) CSB-YP773511OFG
CSB-EP773511OFG
CSB-BP773511OFG
CSB-MP773511OFG
CSB-EP773511OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable mixed-linked glucan synthase 9 (CSLF9), partial CSB-YP773512OFG
CSB-EP773512OFG
CSB-BP773512OFG
CSB-MP773512OFG
CSB-EP773512OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable mannan synthase 7 (CSLA7), partial CSB-YP773513OFG1
CSB-EP773513OFG1
CSB-BP773513OFG1
CSB-MP773513OFG1
CSB-EP773513OFG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable protein phosphatase 2C 35 (At3g06270) CSB-YP773514DOA
CSB-EP773514DOA
CSB-BP773514DOA
CSB-MP773514DOA
CSB-EP773514DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Agamous-like MADS-box protein AGL36 (AGL36) CSB-YP773515DOA
CSB-EP773515DOA
CSB-BP773515DOA
CSB-MP773515DOA
CSB-EP773515DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Histone-lysine N-methyltransferase ASHR1 (ASHR1) CSB-YP773516DOA
CSB-EP773516DOA
CSB-BP773516DOA
CSB-MP773516DOA
CSB-EP773516DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica B3 domain-containing protein Os04g0676600 (Os04g0676600, LOC_Os04g58000) CSB-YP773517OFG
CSB-EP773517OFG
CSB-BP773517OFG
CSB-MP773517OFG
CSB-EP773517OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Beta-glucosidase 12 (BGLU12) CSB-YP773518OFG
CSB-EP773518OFG
CSB-BP773518OFG
CSB-MP773518OFG
CSB-EP773518OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable aquaporin PIP2-6 (PIP2-6), partial CSB-YP773519OFG1
CSB-EP773519OFG1
CSB-BP773519OFG1
CSB-MP773519OFG1
CSB-EP773519OFG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica DEAD-box ATP-dependent RNA helicase 6 (Os04g0533000, LOC_Os04g45040) CSB-YP773520OFG
CSB-EP773520OFG
CSB-BP773520OFG
CSB-MP773520OFG
CSB-EP773520OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Cation transporter HKT4 (HKT4), partial CSB-YP773521OFG
CSB-EP773521OFG
CSB-BP773521OFG
CSB-MP773521OFG
CSB-EP773521OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Squamosa promoter-binding-like protein 8 (SPL8) CSB-YP773522OFG
CSB-EP773522OFG
CSB-BP773522OFG
CSB-MP773522OFG
CSB-EP773522OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Putative magnesium transporter MRS2-D (MRS2-D), partial CSB-YP773523OFG1
CSB-EP773523OFG1
CSB-BP773523OFG1
CSB-MP773523OFG1
CSB-EP773523OFG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Actin-related protein 8 (ARP8) CSB-YP773524OFG
CSB-EP773524OFG
CSB-BP773524OFG
CSB-MP773524OFG
CSB-EP773524OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable metal-nicotianamine transporter YSL6 (YSL6), partial CSB-YP773525OFG
CSB-EP773525OFG
CSB-BP773525OFG
CSB-MP773525OFG
CSB-EP773525OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Putative beta-glucosidase 17 (BGLU17) CSB-YP773526OFG
CSB-EP773526OFG
CSB-BP773526OFG
CSB-MP773526OFG
CSB-EP773526OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Tubby-like F-box protein 7 (TULP7) CSB-YP773527OFG
CSB-EP773527OFG
CSB-BP773527OFG
CSB-MP773527OFG
CSB-EP773527OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable glucuronosyltransferase Os04g0103100 (Os04g0103100, LOC_Os04g01280), partial CSB-YP773528OFG
CSB-EP773528OFG
CSB-BP773528OFG
CSB-MP773528OFG
CSB-EP773528OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Protein argonaute 3 (AGO3), partial CSB-YP773529OFG
CSB-EP773529OFG
CSB-BP773529OFG
CSB-MP773529OFG
CSB-EP773529OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica IAA-amino acid hydrolase ILR1-like 5 (ILL5) CSB-YP773530OFG
CSB-EP773530OFG
CSB-BP773530OFG
CSB-MP773530OFG
CSB-EP773530OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>